435 related articles for article (PubMed ID: 11451350)
41. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.
Miyazaki H; Watabe T; Kitamura T; Miyazono K
Oncogene; 2004 Dec; 23(58):9326-35. PubMed ID: 15531927
[TBL] [Abstract][Full Text] [Related]
42. Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft.
Kim D; Gregory CW; French FS; Smith GJ; Mohler JL
Am J Pathol; 2002 Jan; 160(1):219-26. PubMed ID: 11786415
[TBL] [Abstract][Full Text] [Related]
43. High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.
Bourcigaux N; Gaston V; Logié A; Bertagna X; Le Bouc Y; Gicquel C
J Clin Endocrinol Metab; 2000 Jan; 85(1):322-30. PubMed ID: 10634406
[TBL] [Abstract][Full Text] [Related]
44. Up-regulation of cyclin B1 and cdc2 expression during 9-nitrocamptothecin-induced regression of DU145 prostate tumor.
Chatterjee D; Wyche JH; Pantazis P
Anticancer Res; 2000; 20(6B):4477-82. PubMed ID: 11205291
[TBL] [Abstract][Full Text] [Related]
45. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells.
Delmas D; Passilly-Degrace P; Jannin B; Cherkaoui Malki M; Latruffe N
Int J Mol Med; 2002 Aug; 10(2):193-9. PubMed ID: 12119558
[TBL] [Abstract][Full Text] [Related]
46. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
Musgrove EA; Sarcevic B; Sutherland RL
J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
[TBL] [Abstract][Full Text] [Related]
47. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells.
Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
Neoplasia; 2004; 6(5):646-59. PubMed ID: 15548374
[TBL] [Abstract][Full Text] [Related]
48. Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells.
Knight-Krajewski S; Welsh CF; Liu Y; Lyons LS; Faysal JM; Yang ES; Burnstein KL
Oncogene; 2004 Jul; 23(32):5513-22. PubMed ID: 15077174
[TBL] [Abstract][Full Text] [Related]
49. Mechanical stress reduces podocyte proliferation in vitro.
Petermann AT; Hiromura K; Blonski M; Pippin J; Monkawa T; Durvasula R; Couser WG; Shankland SJ
Kidney Int; 2002 Jan; 61(1):40-50. PubMed ID: 11786083
[TBL] [Abstract][Full Text] [Related]
50. CDK4, a possible critical regulator of apoptosis in rat pheochromocytoma PC12 cells.
Dobashi Y; Shoji M; Kondo E; Akiyama T; Kameya T
Biochem Biophys Res Commun; 1998 Dec; 253(3):609-13. PubMed ID: 9918776
[TBL] [Abstract][Full Text] [Related]
51. Myocardial infarction is coupled with activation of cyclins and cyclin-dependent kinases in myocytes.
Reiss K; Cheng W; Giorando A; De Luca A; Li B; Kajstura J; Anversa P
Exp Cell Res; 1996 May; 225(1):44-54. PubMed ID: 8635516
[TBL] [Abstract][Full Text] [Related]
52. Characterization of a second human cyclin A that is highly expressed in testis and in several leukemic cell lines.
Yang R; Morosetti R; Koeffler HP
Cancer Res; 1997 Mar; 57(5):913-20. PubMed ID: 9041194
[TBL] [Abstract][Full Text] [Related]
53. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.
Masaki T; Shiratori Y; Rengifo W; Igarashi K; Yamagata M; Kurokohchi K; Uchida N; Miyauchi Y; Yoshiji H; Watanabe S; Omata M; Kuriyama S
Hepatology; 2003 Mar; 37(3):534-43. PubMed ID: 12601350
[TBL] [Abstract][Full Text] [Related]
54. Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27.
Waltregny D; Leav I; Signoretti S; Soung P; Lin D; Merk F; Adams JY; Bhattacharya N; Cirenei N; Loda M
Mol Endocrinol; 2001 May; 15(5):765-82. PubMed ID: 11328857
[TBL] [Abstract][Full Text] [Related]
55. Amplified CDK2 and cdc2 activities in primary colorectal carcinoma.
Kim JH; Kang MJ; Park CU; Kwak HJ; Hwang Y; Koh GY
Cancer; 1999 Feb; 85(3):546-53. PubMed ID: 10091728
[TBL] [Abstract][Full Text] [Related]
56. Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro.
Furlanetto RW; Harwell SE; Frick KK
Mol Endocrinol; 1994 Apr; 8(4):510-7. PubMed ID: 8052269
[TBL] [Abstract][Full Text] [Related]
57. Effects of cyclic AMP on components of the cell cycle machinery regulating DNA synthesis in cultured astrocytes.
Gagelin C; Toru-Delbauffe D; Gavaret JM; Pierre M
J Neurochem; 1999 Nov; 73(5):1799-805. PubMed ID: 10537037
[TBL] [Abstract][Full Text] [Related]
58. Prostate cancer cell cycle regulators: response to androgen withdrawal and development of androgen independence.
Agus DB; Cordon-Cardo C; Fox W; Drobnjak M; Koff A; Golde DW; Scher HI
J Natl Cancer Inst; 1999 Nov; 91(21):1869-76. PubMed ID: 10547394
[TBL] [Abstract][Full Text] [Related]
59. Protein kinase C-mediated bidirectional regulation of DNA synthesis, RB protein phosphorylation, and cyclin-dependent kinases in human vascular endothelial cells.
Zhou W; Takuwa N; Kumada M; Takuwa Y
J Biol Chem; 1993 Nov; 268(31):23041-8. PubMed ID: 8226819
[TBL] [Abstract][Full Text] [Related]
60. Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway.
Steiner H; Godoy-Tundidor S; Rogatsch H; Berger AP; Fuchs D; Comuzzi B; Bartsch G; Hobisch A; Culig Z
Am J Pathol; 2003 Feb; 162(2):655-63. PubMed ID: 12547723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
